Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 20/20 | 0.62 |
| ▸ | GNA15 | P30679 | 1/20 | 0.61 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.61 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.61 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.61 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24723608 | 0.90 | FFAR1 (0.79) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL16870114 | 0.90 | FFAR1 (0.79) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL20341605 | 0.87 | FFAR1 (0.67) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL24724168 | 0.83 | FFAR1 (0.59) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL16690541 | 0.82 | FFAR1 (0.64) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL16123793 | 0.81 | FFAR1 (0.82) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL28027397 | 0.79 | FFAR1 (0.60) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL16123789 | 0.78 | FFAR1 (0.73) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL16123746 | 0.78 | FFAR1 (0.80) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL24723627 | 0.77 | FFAR1 (0.65) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3737470-B1 | 3-PHENYL-4-HEXYNOIC ACID DERIVATIVES AS GPR40 AGONISTS | Celon Pharma Sa (PL) | 2022-12-14 | — | — | EP | disclosed |